GRACE EFUNBAJO: Open Payments
NPI 1942827258 · RIVERDALE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,520 in 74 payments from 24 companies in 2025. Trend: 2023 $0 · 2024 $243 · 2025 $1,520
Food & beverage: $1,520
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $324 |
| AstraZeneca Pharmaceuticals LP | 9 | $176 |
| Astellas Pharma US Inc | 5 | $99 |
| Exact Sciences Corporation | 5 | $94 |
| Lilly USA, LLC | 4 | $85 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $81 |
| Kowa Pharmaceuticals America, Inc. | 5 | $78 |
| Vanda Pharmaceuticals Inc. | 3 | $70 |
| Merck Sharp & Dohme LLC | 3 | $66 |
| GlaxoSmithKline, LLC. | 3 | $63 |
Products named: Ozempic, AIRSUPRA, Veozah, Rybelsus, MOUNJARO, CAPLYTA, ZORYVE, The Cologuard Plus Collection Kit.
Industry payments across MD — which companies pay providers there.
